A Euphoria-Suppressing Opioid, Ketan Mehta, Founder & CEO, Tris Pharma
This is the 2026 BioTech Nation "5":
Five Companies Ready to Make a Difference.
We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco.
Five Companies Ready to Make a Difference.
We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco.
On this episode of BioTech Nation...
Ever wonder what makes opioids so addictive? Moira speaks with Ketan Mehta, Founder and CEO of Tris Pharma, about opioid-induced euphoria...and an opioid that's actually meant to suppress this response.
For more information about BioTech Nation and the companies featured here, visit: TechNation.com
